# Mithat Gönen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mithat-gonen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 104,350 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 158 |
| i10-index | 689 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5051277222 |
| ORCID iD | https://orcid.org/0000-0001-8683-8477 |
| Works | 1,348 |

## Researcher papers

- [Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia](https://scholariq.org/papers/efficacy-and-toxicity-management-of-19-28z-car-t-cell-therapy-in-b-cell-acute/)
- [Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients](https://scholariq.org/papers/genomic-characterization-of-metastatic-patterns-from-prospective-clinical/)
- [Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer](https://scholariq.org/papers/adoption-of-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/)
- [Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy](https://scholariq.org/papers/assessment-of-a-watch-and-wait-strategy-for-rectal-cancer-in-patients-with-a/)
- [A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab](https://scholariq.org/papers/a-phase-i-trial-of-regional-mesothelin-targeted-car-t-cell-therapy-in-patients/)
- [Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma](https://scholariq.org/papers/multi-institutional-validation-study-of-the-american-joint-commission-on-cancer/)
- [Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial](https://scholariq.org/papers/neoadjuvant-chemotherapy-without-routine-use-of-radiation-therapy-for-patients/)
- [Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer](https://scholariq.org/papers/overall-survival-with-circulating-tumor-dna-guided-therapy-in-advanced-non-small/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.